Abstract

Risk factors for the development of corneal infection include loose or broken sutures, corticosteroid use, persistent epithelial defects, contact lens use, keratoconjunctivitis sicca, and a history of herpes simplex virus keratitis. Most of the data regarding suture-related keratitis come from literature on penetrating keratoplasty [1]. However, suture-related keratitis following cataract surgery appears to be a rare event [2]. The treatment of bacterial keratitis in patients with or without sutures is similar. In the treatment of serious suture-related corneal infections, topical fortified antibiotic combinations like vancomycin (50 mg/mL) and gentamicin (14 mg/mL) [3] or ceftazidime (50 mg/mL) and vancomycin (50 mg/mL) [3] have been used successfully. However, despite intensive topical, subconjunctival, and systemic antibiotics, corneal perforation can develop [2]. Therefore, selection of the appropriate agent and treatment planning are important for treatment of corneal infections. A beta-lactam antibiotic, imipenem, has often been used systemically and as an intravitreal therapy. However, no study has reported the topical use of imipenem as a monotherapy in the treatment of bacterial keratitis in patients with or without corneal sutures. This report presents the treatment of corneal infection with topical imipenem (50 mg/mL) as monotherapy in a patient who developed an infectious corneal complication due to a broken corneal suture after extracapsular cataract extraction with posterior chamber intraocular lens implantation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call